On November 17, 2022 Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, reported that Chief Executive Officer Masoud Tavazoie, M.D., Ph.D., and Chief Operating Officer David Darst, MBA, will participate in a fireside chat at the Evercore ISI Annual HealthCONx Conference on November 29, 2022 at 4:45pm ET hosted by Evercore ISI research analyst Umer Raffat (Press release, Inspirna, NOV 17, 2022, https://inspirna.com/inspirna-to-present-at-the-evercore-isi-annual-healthconx-conference/ [SID1234624203]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Links to the live and archived versions of the discussion will be available on Inspirna’s website under the News section.